Planned Phase I/II randomized trial

May 10, 2023

Search for:

Recent Posts

United Nations “Unveiling the Future of Intelligent Health in Africa”
Piper Sandler Annual Healthcare Conference
LUGPA 2023 Annual Meeting
Society for Immunotherapy of Cancer’s (SITC) 38th Annual Meeting
Bladder Cancer Advocacy Network’s (BCAN) Annual Bladder Cancer Summit for Patients and Families

Quicklinks

Pipeline
Careers
News and Events
Investors
Contact

Legal

Privacy Policy
Legal Notice
Patent Notice

A member of the NantWorks ecosystem of companies

'Nantkwest’, ‘haNK’, ‘taNK’, ’t-haNK’, ‘ceNK’, ‘NK-92’, ‘Living Drugs in a Bag’, ‘Nature’s First Responder’, ‘Outsmart Your Disease’, and ‘Smart Therapies for Difficult Diseases’ are trademarks or registered trademarks of Nantkwest, ImmunityBio, Inc.

Anktiva is a registered trademark of ImmunityBio, Inc.

The Natural Killer Cell platform consists of investigational agents that are restricted by federal law to investigational use only.

The Natural Killer Cell platform is being investigated in multiple clinical trials across tumor sites.

The content of this website is protected by Title 17 of the U.S. Code and may not be reproduced in whole or in part by any means.

Sitemap